
Novosol Pharmaceuticals Private Limited
About Novosol Pharmaceuticals Private Limited
Data last updated:
Novosol Pharmaceuticals Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 13 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24233UP2012PTC054145. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors including Yogendra Singh and Amul Kumar.
Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office is at H.No.0007 Rapti Nagar Phase IV Near Rana Hospital Chargawa, Gorakhpur, Uttar Pradesh, India – 273001.
As per the financials filed for FY 2016, the company reported a revenue of ₹5.33 Lakh, a decline of 58% compared to the previous year. For the same year it recorded a net profit of ₹2,694 (net margin 0.5%) and EBITDA of ₹74,858 (EBITDA margin 14.1%).
As per MCA filings, the company has open charges of ₹5 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Novosol Pharmaceuticals Private Limited's registered office is in Gorakhpur, Uttar Pradesh.
- Registered AddressH.No.0007 Rapti Nagar Phase IV Near Rana Hospital Chargawa, Gorakhpur, Uttar Pradesh, India – 273001
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Novosol Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Novosol Pharmaceuticals Private Limited, buy the company report.
Financials of Novosol Pharmaceuticals Private Limited
FY 2016 filings availableNovosol Pharmaceuticals Private Limited reported revenue of ₹5.33 Lakh (down 58% YoY) for FY 2016.
Compounded Annual Growth Rate (CAGR)
Revenue fell 58% in the latest year. EBITDA rose 16% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹74,858 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹2,694 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2015-16 | FY 2014-15 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 14.1% | |
| Net Profit Margin | 0.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Novosol Pharmaceuticals Private Limited, buy the company report.
Board of directors of Novosol Pharmaceuticals Private Limited
Novosol Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yogendra Singh Also directs: Applause Media Private Limited | Director | 13 Dec 2012 | 13 Years 10 Months | Current |
| Amul Kumar | Director | 13 Dec 2012 | 13 Years 10 Months | Current |
| Urmila Upadhyay | Director | 13 Dec 2012 | 13 Years 10 Months | Current |
Peer comparison
Novosol Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunvet Homoeo Pharmaceuticals Private Limited | ₹5.35 Lakh (FY 2025) | -4.0% | West Bengal, India | |||
| Solvocare Pharmaceuticals Private Limited | ₹5.34 Lakh (FY 2024) | -14.0% | Chapra, Bihar, India | |||
| Seaford Pharmaceuticals Private Limited | ₹5.34 Lakh (FY 2024) | -10.0% | Hyderabad, Telangana, India | |||
| Novosol Pharmaceuticals Private Limitedthis company | ₹5.33 Lakh (FY 2016) | ₹2,694 | 0.5% | -58.0% | Gorakhpur, Uttar Pradesh, India | |
| Palvik Pharmaceuticals Private Limited | ₹5.32 Lakh (FY 2017) | 19.0% | Delhi, India | |||
| Medmark Pharmaceuticals Private Limited | ₹5.29 Lakh (FY 2025) | -74.0% | Kalyan, Maharashtra, India | |||
| Ryzil Pharmaceuticals Private Limited | ₹5.28 Lakh (FY 2018) | Moradabad, Uttar Pradesh, India |
To see the full peer comparison of Novosol Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Mar 2014 | 10503276 | Andhra Bank | ₹5 Lakh | Open |
To see the full charge records of Novosol Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Novosol Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Novosol Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Novosol Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Novosol Pharmaceuticals Private Limited, buy the company report.
Recent activity
Novosol Pharmaceuticals Private Limited has 3 board changes on record since 2012: 3 appointments. The latest: Amul Kumar was appointed as Director on 13 Dec 2012.
Frequently asked questions
Novosol Pharmaceuticals is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in wholesale, within the trading industry. It was incorporated on 13 December 2012 (14+ years old) and is registered under CIN U24233UP2012PTC054145.
Novosol Pharmaceuticals has 3 current directors:
- Yogendra Singh - Director
- Amul Kumar - Director
- Urmila Upadhyay - Director
The latest financial statements of Novosol Pharmaceuticals on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 30 September 2016. Year-wise statements from 2015 are in the company report.
No. Novosol Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Novosol Pharmaceuticals is U24233UP2012PTC054145. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Novosol Pharmaceuticals was incorporated on 13 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Novosol Pharmaceuticals by revenue are Sunvet Homoeo Pharmaceuticals Private Limited, Solvocare Pharmaceuticals Private Limited, Seaford Pharmaceuticals Private Limited, Palvik Pharmaceuticals Private Limited, Medmark Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Amul Kumar was appointed as Director on 13 Dec 2012. Urmila Upadhyay was appointed as Director on 13 Dec 2012. Yogendra Singh was appointed as Director on 13 Dec 2012.
The registered office of Novosol Pharmaceuticals is at H.No.0007 Rapti Nagar Phase IV Near Rana Hospital Chargawa, Gorakhpur, Uttar Pradesh, India – 273001.
Novosol Pharmaceuticals operates in the trading industry, in the wholesale segment.
Novosol Pharmaceuticals has open charges of ₹5 Lakh and no satisfied charges on record as per latest MCA filings.

